Philippe Charrier, CEO of Labco says the group is not interested in buying reference lab Biomnis before Labco floats. He says the long-awaited Labco IPO, slated for May 2015, should happen "before the summer."
Brazil’s healthcare system is fragmented, inefficient and underfunded. Still, this is Latin America’s largest private healthcare market and is consolidating fast. What are the characteristics of the Brazilian healthcare system? Here we look at the structure of the market and segments such as health insurance, acute care and diagnostics.
Kenyan private equity firm, Ascent (Ascent Capital Africa Ltd), has invested $2.5m in an Ethiopian lab group. Ascent took a 50% stake in Medpharm Holdings Africa and will look to grow the diagnostics laboratory aggressively. We spoke to Guy Brennan, a partner at Ascent.
Manipal Group is investing €35m into the construction of a new 220-bed specialty hospital in Klang, a city of 750,000 in Malaysia. CEO Dr. Ajay Bakshi told Healthcare Nova that the company is aiming to strengthen its presence in India and Malaysia, and recently opened a clinic in Nigeria.
Point-Of-Care-Testing (POCT) technologies are increasingly effective, affordable and available. Consumers can already pick up single-use tests for a variety of conditions from their local pharmacy. Within 1-3 years devices with internet connectivity will transmit health data to mobile devices. Traditional labs will be shielded by POCT’s specific advantages in the short term.
The regeneration of Turkey’s healthcare infrastructure is moving ahead but securing private contractors has proved difficult for laboratory services. Of the 30 health campuses originally planned, 14 are at the tender stage or further. Our sources suggest that only 8-10 will see the light of day due to funding difficulties. But contracts with private operators worth over a billion euros each have already been signed.
It is interesting to note that, so far, the threat posed by a new generation of Point of Care Testing (POCT) technologies doesn’t seem to have damaged the share prices of the worlds largest diagnostic lab groups. Sonic, Labco and Quest are all trading at historic highs in January 2015.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
